Cognate BioServices

Memphis, USAcharlesriver.com1expert edge

Premier cell and gene therapy CDMO offering comprehensive manufacturing for cell therapies, plasmid DNA, and advanced therapeutic medicinal products; acquired by Charles River Labs for $875M in 2021.

Why interesting to a deal team

Expert represented shareholders in $875M sale to Charles River; demonstrates large pharma M&A expertise in high-growth CDMO subsector.

Experts connected to this company

Adam M. WexnerRepresented shareholders in $875M sale to Charles River Labs

Adam M. Wexner

Partner

Kirkland & Ellis LLP

LawyerChicago

He's Kirkland's go-to deal lawyer for pharma-services and CDMO transactions, sitting inside EW Healthcare's and Curewell Capital's live deal pipeline.

Sources

Page titlePressArchived 2021-03-29
businesswire.com/news/home/20210329005536/en/Charles-River-Laboratories-Completes-the-Acquisition-of-Cognate-BioServices
Page titleOther
biospace.com/charles-river-snaps-up-cognate-bioservices-in-875-million-cash-deal
No name matchOther
charlesriver.com

Strongest evidencePage title3 public sourcesHow the grades work